The nation of Zimbabwe has rejected a major American health deal worth 367 million US dollars (272 million pounds) over five years because of Washington's demand for sensitive data.
The decision came to light after a government memo from December was leaked, which showed President Emmerson Mnangagwa felt the deal was "lopsided".
An official spokesperson later clarified that the US was demanding access to genetic material for research and commercial gain while was not willing to guarantee the benefits from any future medical innovations.
"We are forced to start the difficult and regrettable task of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had furnished more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has called for further negotiations to reach a deal agreeable to both sides so the country's vital HIV programme can be sustained.
Wider Background
This development comes after a similar situation in neighbouring Kenya, where a high court blocked a related deal with the US following legal challenges were raised about the security of citizens' health data.
After returning to the presidency last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
USAID had overseen aid for the American government, but Trump claimed its spending was "inefficient" and his government was seeking government-to-government agreements to boost openness and responsibility.
As per reports, Sixteen nations in Africa have so far signed similar agreements, constituting over $18.3bn in new funding.
Specifics of the Rejected Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration could have provided immense advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving HIV treatment through American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its biological resources and data over an extended period, without any corresponding promise of benefiting from any medical innovations – such as new medicines or tests – that might be developed from that provided information," his statement read.
"In essence, our nation would provide the raw materials for scientific discovery without any assurance that the resulting innovations would be accessible to our people if a new disease outbreak emerge."
Sovereignty and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were disrupting systems already set up through the international organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage future global health emergencies.
"This mechanism is designed to guarantee that when a country contributes its data, the benefits – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to create them."
These objections over the US deal "are not meant as hostility towards the US," he added.
"We welcome continued dialogue with our American counterparts on how subsequent co-operation could be structured in a way that respects the independence and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but urged that negotiations must proceed since much of the country's HIV programmes depended on international support.
"If technical issues exist, including those involving data governance or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," the group said.
The halted deal emphasises the complex tensions between accepting much-needed international aid and safeguarding a country's data in an increasingly interconnected world.